Clinical Trials Directory

Trials / Unknown

UnknownNCT04959890

Methodology Study of Retroviral Insertion Site Analysis in Strimvelis Gene Therapy

Methodology Study to Investigate the Utility of Retroviral Insertion Site Analysis in Samples From Subjects Treated With Strimvelis Gene Therapy.

Status
Unknown
Phase
Study type
Observational
Enrollment
15 (estimated)
Sponsor
Fondazione Telethon · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This study is a post approval commitment to evaluate the accuracy and precision of retroviral insertion site (RIS) analysis and its utility for investigating and predicting the potential for insertional oncogenesis in subjects treated with Strimvelis.

Detailed description

This non-interventional, retrospective, methodology study will use peripheral blood and bone marrow samples previously taken from subjects treated with Strimvelis. The study does not require subjects to undergo any further treatment, intervention or blood withdrawal. The objective of this methodology study is to evaluate the accuracy and precision of shearing extension primer tag selection ligation-mediated polymerase chain reaction (S-EPTS/LM-PCR) for RIS analysis and its utility for investigating and predicting the potential for insertional oncogenesis in subjects previously treated with Strimvelis for severe combined immunodeficiency (SCID) due to adenosine deaminase (ADA) deficiency.

Conditions

Interventions

TypeNameDescription
GENETICStrimvelisThis non-interventional, retrospective, methodology study will use peripheral blood and bone marrow samples previously taken from subjects treated with gRV-GT. The study does not require subjects to undergo any further treatment, intervention or blood withdrawal. Eligible samples will be shipped to a central laboratory and will undergo DNA extraction prior to S-EPTS/LM-PCR analysis. Each analysis run will include a control DNA sample and up to four subject samples. Each sample will be analysed in triplicate.

Timeline

Start date
2021-04-23
Primary completion
2024-03-31
Completion
2024-03-31
First posted
2021-07-13
Last updated
2024-01-29

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04959890. Inclusion in this directory is not an endorsement.